神经药理学报 ›› 2016, Vol. 6 ›› Issue (4): 31-36.DOI: 10.3969/j.issn.2095-1396.2016.04.005
张小玲，王真真，温路，邵千航，陈乃宏
出版日期:2016-08-26
发布日期:2016-08-31
通讯作者:
陈乃宏，男，研究员，博士生导师；研究方向：分子神经药理学、中药药理学；Tel/Fax：+86-010-63165177，E-mail：chennh@imm.ac.cn
作者简介:张小玲，女，博士研究生；研究方向：神经药理学和神经生物学；E-mail：zhangxiaoling@imm.ac.cn
基金资助:国家自然科学基金项目（No.81573636、No.U1402221、No.81560663），北京协和医学院“协和青年基金”项目（No.3332016058），中央级公益性科研院所基本科研业务费专项资金项目（No.2014RC03、No.2016RC350002），湖南省教育厅高校科研经费开放基金项目（No.15K091）
ZHANG Xiao-ling，WANG Zhen-zhen，WEN Lu，SHAO Qian-hang，CHEN Nai-hong
Online:2016-08-26
Published:2016-08-31
Contact:
陈乃宏，男，研究员，博士生导师；研究方向：分子神经药理学、中药药理学；Tel/Fax：+86-010-63165177，E-mail：chennh@imm.ac.cn
About author:张小玲，女，博士研究生；研究方向：神经药理学和神经生物学；E-mail：zhangxiaoling@imm.ac.cn
Supported by:国家自然科学基金项目（No.81573636、No.U1402221、No.81560663），北京协和医学院“协和青年基金”项目（No.3332016058），中央级公益性科研院所基本科研业务费专项资金项目（No.2014RC03、No.2016RC350002），湖南省教育厅高校科研经费开放基金项目（No.15K091）
摘要： 抑郁症（depression）是一种发病机制复杂的常见精神疾病，以显著而持久的心境低落和认知功能障碍为主要临床特征。越来越多的研究表明，长期慢性应激能够激活外周以及中枢免疫系统，通过释放大量炎性介质（包括细胞因子）导致与抑郁症相关的各种行为。该文试图对细胞因子（包括促炎细胞因子和抗炎细胞因子）与抑郁症的关系做一简要综述。
张小玲，王真真，温路，邵千航，陈乃宏. 细胞因子与抑郁症关系的研究进展[J]. 神经药理学报, 2016, 6(4): 31-36.
ZHANG Xiao-ling，WANG Zhen-zhen，WEN Lu，SHAO Qian-hang，CHEN Nai-hong. The Relationship between Cytokines and Depression[J]. Acta Neuropharmacologica, 2016, 6(4): 31-36.
| [1] Greden J F. The burden of disease for treatment-resistant depression [J]. J Clin Psychiatry, 2001, 62(16): 26-31.[2] Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study [J]. Lancet, 1997, 349 (9064): 1498-1504.[3] Ronald C Kessler. The costs of depression [J].Psychiatr Clin North Am, 2012, 35(1): 1-14.[4] Adrian J Dun, Artur H Swiergiel. Effects of interleukin-1 and endotoxin in the forced swim and tail suspension tests in mice [J]. Pharmacol Biochem Behav, 2005, 81(3): 688-693.[5] Andrey M Mazarati, Eduardo Pineda, Don Shin, et al. Comorbidity between epilepsy and depression: role of hippocampal interleukin-1β [J]. Neurobiol Dis, 2010, 37(2): 461-467.[6] Donn A Simmons, Patricia A Broderick. Cytokines, stressors, and clinical depression: Augmented adaptation responses underlie depression pathogenesis [J]. Prog Neuropsychopharmacol Biol Psychiatry, 2005, 29(5):793-807.[7] Nicole Lichtblau, Frank Martin Schmidt, Robert Schumann, et al. Cytokines as biomarkers in depressive disorder: current standing and prospects [J]. Int Rev Psychiat, 2013, 25(5): 592-603.[8] Amisha Patel. Review: the role of inflammation in depression [J]. Psychiatria Danubina, 2013, 25(2): 216-223.[9] Sinead M O Brien, Lucinda V Scott, Timothy G Dinan. Cytokines: abnormalities in major depression and implications for pharmacological treatment [J]. Hum Psychopharmacol, 2004, 19(6): 397-403.[10] Olga J G Schiepers, Marieke C Wichers, Michael Maes. Cytokines and major depression [J]. Prog Neuropsychopharmacol Biol Psychiatry, 2005, 29(2): 201-217.[11] 徐说，林文娟．抗炎性细胞因子与抑郁症 [J]. 生物化学与生物物理进展，2014，41(11) : 1099-1108．[12] 苑杰，严辞，刘昊，等．抑郁症生物标志物研究进展 [J]．国际精神病学杂志，2015，42(2) : 103-107.[13] Ja Woo Koo, Ronald S Duman. IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress [J]. Proc Natl Acad Sci U S A, 2008, 105(2): 751-756.[14] Greg Norman, Kate Karelina, Zhang N, et al. Stress and IL-1beta contribute to the development of depressive-like behavior following peripheral nerve injury [J]. Mol Psychiatry, 2010, 15(4): 404-414.[15] Anna Gadek-Michalska, Joanna Tadeusz, Paulina Rachwalska, et al. Cytokines, prostaglandins and nitric oxide in the regulation of stress-response systems [J]. Pharmacol Rep, 2013, 65 (6): 1655-1662.[16] Levine J, Barak Y, Chengappa K N, et al. Cerebrospinal cytokine levels in patients with acute depression [J]. Neuropsychobiology, 1999, 40(4): 171-176.[17] Owen B M, Eccleston D, Ferrier I N, et al. Raised levels of plasma interleukin-1beta in major and postviral depression [J]. Acta Psychiatr Scand, 2001, 103 (3): 226-228.[18] Brambilla F, Maurizio Maggioni. Blood levels of cytokines in elderly patients with major depressive disorder [J]. Acta Psychiatr Scand, 1998, 97 (4): 309-313.[19] Yekta Dowlati, Nathan Herrmann, Walter Swardfager, et al. A meta-analysis of cytokines in major depression [J]. Biol Psychiatry, 2010, 67(5): 446-457.[20] Ariyuki Kagaya, Akira Kugaya, Minoru Takebayashi, et al. Plasma concentrations of interleukin-1beta, interleukin-6 soluble interleukin-2 receptor and tumor necrosis factor alpha of depresse patients in Japan [J]. Neuropsychobiology, 2001, 43(2): 59-62.[21] Jose M Martinez, Amir Garakani, Rachel Yehuda, et al. Proinflammatory and “resiliency” proteins in the CSF of patients with major depression [J]. Depress Anxiety, 2012, 29(1): 32-38.[22] Rai Khalid Farooq, Elsa Isingrini, Arnaud Tanti, et al. Is unpredictable chronic mild stress (UCMS) a reliable model to study depression-induced neuroinflammation? [J]. Behav Brain Res, 2012, 231 (1): 130-137.[23] Cecile Mormede, Nathalie Castanon, Chantal Medina, et al. Chronic mild stress in mice decreases peripheral cytokine and increases central cytokine expression independently of IL-10 regulation of the cytokine network [J]. Ann NY Acad Sci, 2002, 10 (6): 359-366.[24] Ghanshyam N Pandey, Hooriyah S Rizavi, Ren Xin-guo, et al. Proin?ammatory cytokines in the prefrontal cortex of teenage suicide victims [J]. J Psychiatr Res, 2012, 46 (1): 57-63.[25] You Zi-li, Luo Chun-mei, Zhang Wen-zheng, et al. Pro- and anti-inflammatory cytokines expression in rat’s brain and spleen exposed to chronic mild stress: involvement in depression [J]. Behav Brain Res, 2011, 225 (1): 135-141.[26] Nicholas J Van Wagoner, Etty N Benveniste. Interleukin-6 expression and regulation in astrocytes [J]. J Neuroimmunol, 1999, 100(1-2):124-39.[27] Willscott E Naugler, Michael Karin. The wolf in sheep’s clothing: the role of interleukin-6 in immunity, inflammation and cancer [J]. Trends Mol Med, 2008, 14(3):109-119.[28] Goldstein B I, Kemp D E, Soczynska J K, et al. Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature [J]. J Clin Psychiatry, 2009, 70(8):1078-1090.[29] Howren M Bryant, Lamkin Donald M, Suls Jerry. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis [J]. Psychosom Med, 2009, 71(2):171-186.[30] Eric P Zorrilla, Lester Luborsky, James R McKay, et al. The relationship of depression and stressors to immunological assays: a meta-analytic review [J]. Brain Behav Immun, 2001, 15(3):199-226.[31] Michael Maes, Herbert Y Meltzer, Eugene Bosmans, et al. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression [J]. J Affect Disord, 1995, 34(4):301-309.[32] Petr Bob, Jiri Raboch, Michael Maes, et al. Depression, traumatic stress and interleukin-6 [J]. J Affect Disord, 2010, 120(1-3):231-234.[33] Su Shao-yong, Andrew H Miller, Harold Snieder, et al. Common genetic contributions to depressive symptoms and inflammatory markers in middle-aged men: the Twins Heart Study[J]. Psychosom Med, 2009, 71(2):152-158.[34] Daniel Lindqvist, Shorena Janelidze, Pater Hagell, et al Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity [J]. Biol Psychiatry, 2009, 66(3):287-292.[35] Shorena Janelidze, Daniele Mattei, Asa Westrin, et al. Cytokine levels in the blood may distinguish suicide attempters from depressed patients [J]. Brain Behav Immun, 2011, 25(2):335-339.[36]Sabine Chourbaji, Alexandre Urani, Ioana Inta, et al. IL-6 knockout mice exhibit resistance to stress-induced development of depression-like behaviors [J]. Neurobiol Dis, 2006, 23(3):587-594.[37] Klemen Strle, Zhou Jian-hua, Wen H Shen, et al. lnterleukin-10 in the brain [J]. Critical Reviews TM in Immunology, 2001, 21(5):427-449.[38]Song C, Halbreich U, Han C, et al. Imbalance between pro-and anti-inflammatory cytokines, and between Th1 and Th2 cytokines in depressed patients:the effect of electroacupuncture or fluoxetine treatment [J]. Pharmacopsychiatry, 2009, 42(05): 182-188.[39] Firdaus S Dhabhar, Heather M Burke, Elissa S Epel, et al. Low serum IL-10 concentrations and loss of regulatory association between IL-6 and IL-10 in adults with major depression [J]. J Psychiat Res, 2009, 43(11): 962-969.[40] Pan Yu-qin, Lin Wen-juan, Wang Wei-wen, et al. The effects of central pro-and anti-inflammatory immune challenges on depressive-like behavior induced by chronic forced swim stress in rats [J]. Behavi Brain Res, 2013, 247: 232-240[41] Levent Sutcigil, Cagatay Oktenli, Ugur Musabak, et al. Pro-and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy [J]. Clin Develop Immunol, 2007, 2007: 76396[42] Fili Fazzino, Francisco Obregón, Margarita Morles, et al. Taurine transporter in lymphocytes of patients with major depression treated with venlafaxine plus psychotherapy [J]. Adv Exp Med Biol, 2009, 643: 217-224.[43] Ashley M Fenn, Christopher J Henry, Huang Yan, et al. Lipopolysaccharide-induced interleukin (IL)-4 receptor-α expression and corresponding sensitivity to the M2 promoting effects of IL-4 are impaired in microglia of aged mice [J]. Brain Behav Immun, 2012, 26(5): 766-777.[44] Godbout J P, Fenn A, Huang Y, et al. Central interleukin-4 infusion after a peripheral lipopolysaccharide injection promotes a neuroprotective CNS environment with increased M2 microglia [J]. Brain Behav Immun, 2012, 26(1): S29-S30.[45] Brian E Leonard. Inflammation, depression and dementia: are they connected?[J].Neurochem Res, 2007, 32(10): 1749-1756.[46] Simon N M, McNamara K, Chow C W, et al. A detailed examination of cytokine abnormalities in Major Depressive Disorder [J]. Euro Neuropsychopharmacol, 2008, 18(3): 230-233.[47] Fred D Finkelman, Terez Shea-Donohue, Suzanne C Morris, et al. Interleukin-4 and interleukin-13 mediated host protection against intestinal nematode parasites [J]. Immunol Rev, 2004, 201(1): 139-155.[48] Hymie Anisman, Zul Merali, Michael Owen Poulter, et al. Cytokines as a precipitant of depressive illness: animal and human studies [J]. Curr Pharm Des, 2005, 11(8): 963-972.[49] Müller N, Schwarz M J. The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression [J]. Mol Psychiatry, 2007, 12: 988-1000.[50] Adam K Walker, Annemieke Kavelaars, Heijen C J, et al. Neuroin?ammation and comorbidity of pain and depression [J]. Pharmacol Rev, 2013, 66 (1): 80-101.[51] Hideki Miura, Norio Ozaki, Makoto Sawada, et al. A link between stress and depression: Shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression [J]. Stress, 2008, 11(3): 198-209.[52] Zhang Kun, Xu Hai-yun, Cao Long-long, et al. Interleukin-1β inhibits the differentiation of hippocampal neural precursor cells into serotonergic neurons[J]. Brain Res, 2012, 1490: 193-201.[53] Manocha M, Shajib MS, Rahman MM, et al. IL-13-mediated immunological control of enterochromaffin cell hyperplasia and serotonin production in the gut[J]. Mucosal Immunology, 2012, 6(1): 146-155.[54] Zhu Chong-bin, Randy D Blakely, William A Hewlett. The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters [J]. Neuropsychopharmacology, 2006; 31(10):2121-2131.[55] Wichers M C, Kenis G, Koek G H, et al. Interferon-alpha-induced depressive symptoms are related to changes in the cytokine network but not to cortisol [J]. J Psychosom Res, 2007, 62(2): 207-214.[56] Benrick A，Schéle E，Pinnock S B，et al． Interleukin-6 gene knockout influences energy balance regulating peptides in the hypothalamic paraventricular and supraoptic nuclei [J]．J Neuroendocrinol, 2009, 21(7): 620-628．[57] Marieke Wichers, Michael Maes. The role of indoleamine 2, 3 dioxygenase (IDO) in the pathophysiology of interferon-alpha- induced depression [J]. J Psychiatry Neurosci, 2004, 29 (1): 11-17.[58] Zhang Gong-liang, Zhao Bing-xue, Hua Rong, et al．Hippocampal microglial activation and glucocorticoid receptor down-regulation precipitate visceral hypersensitivity induced by colorectal distension in rats[J]. Neuropharmacology, 2016, 102:295-303. [59] Jennifer C Felger, Ebrahim Haroon, Bobbi J Woolwine, et al．Interferon-alpha-induced inflammation is associated with reduced glucocorticoid negative feedback sensitivity and depression in patients with hepatitis C virus[J]. Physiol Behav, 2016, 166:14-21. |
| [1] | 付至江， 高云，张伟，等. 抑郁症对大鼠骨折愈合的影响的实验研究[J]. 神经药理学报, 2018, 8(6): 1-8. |
| [2] | 王健辉，程肖蕊，张小锐，刘港，周文霞，张永祥. 药物组合吲哚美辛与阿托伐他汀对阿尔茨海默病的治疗作用研究[J]. 神经药理学报, 2018, 8(2): 52-52. |
| [3] | 肖 婷，马天阳， 徐祥清， 王克威. 大鼠慢性不可预测温和应激与小鼠社会挫败抑郁症模型的建立与行为学评价[J]. 神经药理学报, 2018, 8(1): 45-53. |
| [4] | 张阔，杨静玉，吴春福. 抑郁症的病理生理学基础及动物模型研究进展[J]. 神经药理学报, 2017, 7(4): 8-16. |
| [5] | 任倩，王真真，陈乃宏. MicroRNA调控神经可塑性在抑郁症中作用研究进展[J]. 神经药理学报, 2017, 7(3): 12-20. |
| [6] | 邹征强，程玉芳，汪海涛，周中振，陈佳佳，冯红方，徐江平. PDE4 抑制剂FCPR03 对LPS 诱导小鼠抑郁样行为的改善作用及其机制研究[J]. 神经药理学报, 2017, 7(3): 43-43. |
| [7] | 詹向红*，刘永，宋萍，韩贺云，潘玉颖，孙前明. 轻中度抑郁症患者认知功能损伤的事件相关电位研究[J]. 神经药理学报, 2017, 7(3): 52-52. |
| [8] | 钟秋萍，钟佳宏，余汇，程玉芳，汪海涛，徐江平*. 新型PDE4抑制剂FCPR16的抗抑郁作用及机制研究[J]. 神经药理学报, 2017, 7(3): 57-57. |
| [9] | 杜贯涛，林井然，刘广军，洪浩. 阿尔茨海默病与抑郁症共病研究进展[J]. 神经药理学报, 2016, 6(6): 40-44. |
| [10] | 曹利华，白明，方晓艳，王灿，苗明三. 基于临床病症特点的抑郁症动物模型分析[J]. 神经药理学报, 2016, 6(4): 19-23. |
| [11] | 王莎莎，张钊，张美金，胡金凤，陈乃宏. Nrf2/ARE信号通路在抑郁症中的研究进展[J]. 神经药理学报, 2016, 6(3): 32-37. |
| [12] | 何海然, 薛占霞. 抑郁症相关发病机制的研究进展[J]. 神经药理学报, 2016, 6(2): 20-25. |
| [13] | 李牧函，余冰颖，刘屏. 胞外信号调控激酶（ERK）信号通路与抑郁症[J]. 神经药理学报, 2015, 5(1): 38-44. |
| [14] | 陈姣，楚世峰，王真真，陈乃宏 . GSK3在抑郁症发病机制中的研究进展[J]. 神经药理学报, 2014, 4(5): 44-54. |
| [15] | 李婧 孙建栋 苑玉和 陈乃宏. 谷氨酸能神经传递在抑郁症发病机制中的研究进展[J]. 神经药理学报, 2014, 4(1): 20-24. |
| 阅读次数 | ||||||
|
全文 |
|
|||||
|
摘要 |
|
|||||
